Allurion Technologies (ALUR) Net Cash Flow (2022 - 2026)
Allurion Technologies (ALUR) posted Net Cash Flow of -$355000.0 for Q1 2026, up 50.9% on a QoQ basis from -$723000.0 in Q4 2025, and down 107.06% year-over-year from $5.0 million in Q1 2025.
Allurion Technologies (ALUR) Net Cash Flow (2022 - 2026) Analysis & Trends
Allurion Technologies' Net Cash Flow history runs 5 years deep, the most recent figure standing at -$355000.0 for Q1 2026.
- Quarterly Net Cash Flow fell 107.06% year-over-year to -$355000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.4 million (down 64.18% YoY) and the FY2025 annual result came in at -$10.0 million, up 56.06% from the prior year.
- Net Cash Flow was -$355000.0 for Q1 2026 at Allurion Technologies, up from -$723000.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $75.0 million in Q3 2023 and bottomed at -$41.7 million in Q4 2023.
- A 5-year average of -$293333.3 and a median of -$1.6 million in 2022 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 41310.99% in 2023, while the deepest fall reached 2566.62% in 2023.
- Allurion Technologies' Net Cash Flow stood at -$1.6 million in 2022, then sank by 2566.62% to -$41.7 million in 2023, then surged by 68.05% to -$13.3 million in 2024, then soared by 94.57% to -$723000.0 in 2025, then surged by 50.9% to -$355000.0 in 2026.
- Business Quant data shows ALUR's Net Cash Flow at -$355000.0 in Q1 2026, -$723000.0 in Q4 2025, and -$6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -355,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -355,000.00 |
| Mar 31, 2026 | -355,000.00 |
| Dec 31, 2025 | -723,000.00 |
| Dec 31, 2025 | -723,000.00 |
| Sep 30, 2025 | -6.58 Mn |
| Sep 30, 2025 | -6.58 Mn |
| Jun 30, 2025 | -7.70 Mn |
| Jun 30, 2025 | -7.70 Mn |
| Mar 31, 2025 | 5.03 Mn |
| Mar 31, 2025 | 5.03 Mn |
| Dec 31, 2024 | -13.33 Mn |
| Dec 31, 2024 | -13.33 Mn |
| Sep 30, 2024 | 9.44 Mn |
| Sep 30, 2024 | 9.44 Mn |
| Jun 30, 2024 | -10.50 Mn |
| Jun 30, 2024 | -10.50 Mn |
| Mar 31, 2024 | -8.32 Mn |
| Mar 31, 2024 | -8.32 Mn |
| Dec 31, 2023 | -41.71 Mn |
| Dec 31, 2023 | -41.71 Mn |